Sunstone Therapies
@SunstoneHeals
Leading the research and delivery of psychedelic assisted therapies for those affected by cancer and complex mental health challenges and disorders.
Today, on International Clinical Trials Day, Sunstone celebrates the vital role clinical research plays in shaping the future of healthcare. We’re proud to contribute to this legacy through our work in psychedelic-assisted therapy, with a growing portfolio of active clinical…
Join Sunstone’s Therapist Program Director, Rachel Winzer, and guest speaker, Dr. Nadav Liam Modlin, Psychology & Psychotherapy Lead in Psychedelics at King’s College London, to discuss how to provide personalized therapeutic care while upholding rigorous research protocols.…
Are you, or someone you know, curious about FDA-approved psychedelic-assisted therapy clinical trials? This innovative field is rapidly evolving, and we invite you to join our upcoming webinar to hear Dr. Manish Agrawal, Sunstone's CEO and Principal Investigator, as he discusses…
How do you provide personalized therapeutic care while upholding rigorous research protocols? This crucial question is at the heart of our upcoming webinar for Therapists and Mental Health Providers. Join Sunstone's Rachel Winzer and King's College London's Dr. Nadav Liam Modlin…
We’re pleased to announce the publication of our Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with Cancer Study in @JournalCancer, the Journal of the American Cancer Society! Led by our CEO and Principal Investigator, Dr. Manish Agrawal, this study…
Can a psychedelic compound from mushrooms benefit people with cancer and major depression? 🍄 Results from a phase 2 study reveals that a single dose of psilocybin offers long-term relief from symptoms of depression and anxiety: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @OncoAlert @SunstoneHeals
Sunstone will be at @PsychedelicSci in Denver next week, and we’re looking forward to the meaningful conversations that always come from gathering with fellow researchers, scientists, and colleagues in the field. Here’s where to find us and join the dialogue!
You're Invited: Open House for Mental Health Providers and Referring Clinicians Join us in person on Tuesday, June 10 to connect with our clinical team, explore our ongoing clinical trials focused on complex mental health conditions, and learn more about the innovative care we…
Therapists, join us for a focused conversation on preparation in psychedelic-assisted therapy. Sunstone’s Therapist Program Director, Rachel Winzer, will be joined by guest speaker Nadav Liam Modlin, Psychology & Psychotherapy Lead in Psychedelics at King’s College London.…
Thank you, Melissa Lavasani and @PMCinDC Coalition, for inviting Sunstone’s CEO, Dr. Manish Agrawal, to be part of the Federal Summit on Psychedelic Medicine to speak about our work at Sustone and how we’re contributing to thoughtful, evidence-based integration of psychedelic…
